Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APEX1 | P27695 | 1/20 | 0.81 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 2/20 | 0.37 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.35 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.35 |
| ▸ | CDC25A | P30304 | 1/20 | 0.35 |
| ▸ | CDC25B | P30305 | 1/20 | 0.35 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15691725 | 0.92 | APEX1 (0.96) | APEX1THRBTDP1PDK2NPC1 | |
| SCHEMBL5866539 | 0.90 | APEX1 (1.00) | APEX1THRBTDP1PDK2NPC1 | |
| SCHEMBL29512333 | 0.90 | APEX1 (1.00) | APEX1THRBTDP1PDK2NPC1 | |
| SCHEMBL29512337 | 0.90 | APEX1 (1.00) | APEX1THRBTDP1PDK2NPC1 | |
| SCHEMBL29441930 | 0.90 | APEX1 (1.00) | APEX1THRBTDP1PDK2NPC1 | |
| SCHEMBL17050245 | 0.89 | APEX1 (0.73) | APEX1THRBTDP1PGRPDK2 | |
| SCHEMBL24179777 | 0.83 | APEX1 (0.86) | APEX1THRBTDP1PDK2NPC1 | |
| SCHEMBL5990939 | 0.83 | APEX1 (0.73) | APEX1TDP1CYP2C19 | |
| SCHEMBL15691574 | 0.83 | APEX1 (0.86) | APEX1THRBTDP1PDK2NPC1 | |
| SCHEMBL18663270 | 0.81 | APEX1 (0.83) | APEX1THRBTDP1PDK2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9518150-B2 | Resin composition, stretched film, circularly polarizing plate, and image display device | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-12-13 | — | — | US | disclosed |
| US-20150247002-A1 | RESIN COMPOSITION, STRETCHED FILM, CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150247002-A1 | RESIN COMPOSITION, STRETCHED FILM, CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | RAD50, RAD54L, PUF60 | APEX1 3376/4885THRB 3988/4885TDP1 3587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.